127 related articles for article (PubMed ID: 25520875)
1. Identification and verification of Hsp90-beta as a potential serum biomarker for lung cancer.
Rong B; Zhao C; Liu H; Ming Z; Cai X; Gao W; Yang S
Am J Cancer Res; 2014; 4(6):874-85. PubMed ID: 25520875
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum annexin A1 as potential diagnostic marker for lung cancer: a retrospective case-control study.
Rong B; Zhao C; Liu H; Ming Z; Cai X; Gao W; Yang S
Am J Transl Res; 2014; 6(5):558-69. PubMed ID: 25360220
[TBL] [Abstract][Full Text] [Related]
3. Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.
Biaoxue R; Min L; Tian F; Wenlong G; Hua L
BMC Pulm Med; 2018 Dec; 18(1):188. PubMed ID: 30522463
[TBL] [Abstract][Full Text] [Related]
4. Increased level of Hsp90-beta in bronchoalveolar lavage fluid correlates with lymphatic invasion and advanced stage of lung cancer patients.
Rong B; Cai X; Liu H; Fu T; Gao W; Zhao C; Lin Y
Am J Transl Res; 2016; 8(10):4147-4159. PubMed ID: 27829999
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients.
Biaoxue R; Xiling J; Shuanying Y; Wei Z; Xiguang C; Jinsui W; Min Z
J Exp Clin Cancer Res; 2012 Aug; 31(1):70. PubMed ID: 22929401
[TBL] [Abstract][Full Text] [Related]
6. Co-overexpression of Hsp90-β and annexin A1 with a significantly positive correlation contributes to the diagnosis of lung cancer.
Biaoxue R; Shuanying Y; Wei L; Zongjuan M; Xiguang C; Qiuhong Z
Expert Rev Mol Diagn; 2014 Nov; 14(8):1067-79. PubMed ID: 25300907
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients.
Wu Y; Huang B; Liu Q; Liu Y
Int J Clin Exp Pathol; 2015; 8(7):8252-9. PubMed ID: 26339394
[TBL] [Abstract][Full Text] [Related]
8. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.
Zhang K; Chen L; Deng H; Zou Y; Liu J; Shi H; Xu B; Lu M; Li C; Jiang J; Wang Z
Int J Clin Exp Pathol; 2015; 8(1):629-35. PubMed ID: 25755755
[TBL] [Abstract][Full Text] [Related]
9. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
[TBL] [Abstract][Full Text] [Related]
10. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Identification and verification of Hsp90-beta as a potential serum biomarker for lung cancer.
Rong B; Zhao C; Liu H; Ming Z; Cai X; Gao W; Yang S
Am J Cancer Res; 2016; 6(6):1460. PubMed ID: 27429859
[TBL] [Abstract][Full Text] [Related]
12. Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer.
Lai Y; Wang X; Zeng T; Xing S; Dai S; Wang J; Chen S; Li X; Xie Y; Zhu Y; Liu W
J Cancer; 2018; 9(9):1538-1547. PubMed ID: 29760791
[No Abstract] [Full Text] [Related]
13. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
Li W; Li N; Kang X; Shi K
Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of serum miR-661 in diagnosis and prognosis of non-small cell lung cancer.
Zhou GH; Yang WH; Sun B
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5696-5701. PubMed ID: 29272005
[TBL] [Abstract][Full Text] [Related]
15. An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors.
Dakappagari N; Neely L; Tangri S; Lundgren K; Hipolito L; Estrellado A; Burrows F; Zhang H
Biomarkers; 2010 Feb; 15(1):31-8. PubMed ID: 19747088
[TBL] [Abstract][Full Text] [Related]
16. CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer.
Sun L; Wang Y; Yuan H; Burnett J; Pan J; Yang Z; Ran Y; Myers I; Sun D
J Cancer; 2016; 7(10):1197-204. PubMed ID: 27390594
[TBL] [Abstract][Full Text] [Related]
17. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
[TBL] [Abstract][Full Text] [Related]
18. Potential Prognostic Value of Histone Deacetylase 6 and Acetylated Heat-Shock Protein 90 in Early-Stage Breast Cancer.
Park Y; Lee KS; Park SY; Kim JH; Kang EY; Kim SW; Eom KY; Kim JS; Kim IA
J Breast Cancer; 2015 Sep; 18(3):249-55. PubMed ID: 26472975
[TBL] [Abstract][Full Text] [Related]
19. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
[TBL] [Abstract][Full Text] [Related]
20. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
